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Abstract
Background
Sexually transmitted infections spread across contact networks. Partner elicitation and noti-
fication are commonly used public health tools to identify, notify, and offer testing to persons
linked in these contact networks. For HIV-1, a rapidly evolving pathogen with low per-con-
tact transmission rates, viral genetic sequences are an additional source of data that can be
used to infer or refine transmission networks.
Methods and Findings
The New York City Department of Health and Mental Hygiene interviews individuals newly
diagnosed with HIV and elicits names of sexual and injection drug using partners. By law, the
Department of Health also receives HIV sequences when these individuals enter healthcare
and their physicians order resistance testing. Our study used both HIV sequence and partner
naming data from 1342 HIV-infected persons in New York City between 2006 and 2012 to
infer and compare sexual/drug-use named partner and genetic transmission networks. Using
these networks, we determined a range of genetic distance thresholds suitable for identifying
potential transmission partners. In 48% of cases, named partners were infected with geneti-
cally closely related viruses, compatible with but not necessarily representing or implying,
direct transmission. Partner pairs linked through the genetic similarity of their HIV sequences
were also linked by naming in 53% of cases. Persons who reported high-risk heterosexual
contact were more likely to name at least one partner with a genetically similar virus than
those reporting their risk as injection drug use or men who have sex with men.
Conclusions
We analyzed an unprecedentedly large and detailed partner tracing and HIV sequence
dataset and determined an empirically justified range of genetic distance thresholds for
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identifying potential transmission partners. We conclude that genetic linkage provides more
reliable evidence for identifying potential transmission partners than partner naming,
highlighting the importance and complementarity of both epidemiological and molecular
genetic surveillance for characterizing regional HIV-1 epidemics.
Author Summary
Understanding the path over which viruses such as HIV have been transmitted may be
crucial for directing public health resources and guiding policy decisions. Contact tracing
of named sexual and injection drug-use partners of people recently diagnosed with HIV is
an indispensible tool for reconstructing this transmission network. Viral genetic sequence
data—routinely collected by public health agencies—can also be used to infer the dynam-
ics of HIV transmission. We analyzed partner naming and viral genetic sequence data in
1342 people living with HIV in New York City reported to the New York City Department
of Health and Mental Hygiene between 2006 and 2012. Genetically linked partners were
more likely to be named partners than named partners were to be genetically linked. This
finding indicates that genetic sequence data are better than partner naming data for
reconstructing this viral transmission network. Importantly, the success rate in naming a
genetically linked partner varied by transmission risk category (e.g., men who have sex
with men, heterosexuals, and injection drug users). This study validates the use viral
genetic sequences in reconstructing these viral transmission networks in a public health
surveillance setting.
Introduction
Analysis of pathogen genetics has shaped our understanding of the origin and spread of
numerous infectious diseases, both viral and bacterial [1–5]. Genetic sequence analyses deter-
mined that the HIV-1 group M pandemic has zoonotic origins in chimpanzees [6, 7] and how
HIV has migrated within and out of sub-Saharan Africa [8–10]. On a smaller scale, genetic
sequence analyses are used to clarify dynamics of local HIV-1 transmission networks [11–16],
which can be in turn used to target HIV prevention and intervention strategies [15, 17–19].
HIV transmission largely occurs along links in the social network connecting risk-sharing
partners (e.g., injection drug users or sexual contacts), which represent potential routes of viral
spread. The HIV transmission network is a subset of all of the risk exposure interactions. Tech-
niques for reconstructing HIV transmission networks from viral sequence data provide an
estimate of the unobserved transmission network [11, 15, 20–23] but cannot exclude unob-
served intermediate or shared sources of infections [24] (i.e., two genetically linked individuals
are close to each other in the true transmission network but not necessarily directly con-
nected). Genetic distance based methods [11, 16, 21, 23] ascribe a putative transmission link to
any pair of viral sequences that are within a predetermined genetic distance threshold, with
the expectation that viral genetic diversity between transmission partners should approximate
the diversity within the source partner [21], and allow for some degree of onward evolution in
the recipient partner. Within a single person, HIV pol sequences (the genomic region routinely
used in public health surveillance for antiretroviral drug resistance) tend not diverge more
than 0.01 substitutions/site from the baseline sequence in the first 10 years of infection [25],
and the total sequence divergence tends to be less than 0.02 substitutions/site [21]. Therefore,
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one would expect an epidemiologically meaningful genetic distance threshold for identifying
transmission partners to fall between 0.01 and 0.02 substitutions/site. This range is consistent
with previous observations [21, 26], but has not yet been empirically validated using named
partners in a surveillance setting.
It is estimated that over 100,000 people residing in New York City, approximately 1.2% of
the city’s population, are infected with HIV [27]. Among persons documented to be living
with HIV/AIDS in New York City, the largest proportions comprise men who have sex with
men (MSM, 37.4%) and Blacks/African Americans (44.4%). To identify new HIV cases and
promote linkage to care, the Field Services Unit (FSU) of the New York City Department of
Health and Mental Hygiene (DOHMH) interviews persons newly diagnosed with HIV infec-
tion (index cases), and elicits names of sexual or drug using partners in the past year (named
partners). This partner tracing evinces only a fraction of all risk exposure connections that
may have led to index HIV infections, or infections originating from index cases. After the
interview, the named partners are notified of their exposure and offered HIV testing. When
resistance testing is ordered by a physician with whom the index case or an HIV-positive
partner has initiated care, the partial nucleotide sequence of the HIV pol gene is reported to
DOHMH surveillance. These sequence data can then be used to reconstruct an HIV genetic
transmission network [28, 29].
Key to designing and monitoring effective HIV prevention strategies is the identification of
partners who transmitted HIV to each other; however, unambiguously identifying these part-
ners is nearly impossible [24, 30, 31]. Our best indication that a transmission partner pair is
correctly inferred is when the partners are linked both socially (named partners) and geneti-
cally (highly similar viral sequences). Previous investigations into inferred social and genetic
networks in HIV focused on small, homogeneous populations of high-risk individuals [26, 32–
35] and found that named partners were often not transmission partners; their viruses were
too genetically dissimilar. Our study used an order of magnitude larger number of individuals
(1342 people), with diverse risk factors, to investigate the use of a genetic distance threshold
for identifying potential transmission partners (i.e., partners with a direct or indirect epidemi-
ological connection) in a surveillance setting. We validate a range of biologically and epidemi-
ologically plausible genetic distance thresholds and find that the degree of concordance
between social (i.e., named partner) and genetic networks in New York City is relatively low
and varies by risk factor and race/ethnicity. Based on these results, we suggest avenues to
improve HIV surveillance and public health intervention activities.
Methods
Index case and named partner population
The FSU interviewed index cases diagnosed with HIV in the previous three months and elic-
ited the names of partners who had engaged in sexual activity or injection drug use (IDU) with
the index case in the previous 12 months. Named partners were contacted and referred to
care; many of these named partners were also index cases in this population. Only the primary
transmission risk factor was considered when classifying index cases and named partners
whose genotype was reported to surveillance. For classification purposes, history of injection
drug use took precedence over sexual risk behavior. Persons who did not report high-risk sex-
ual activity were classified as having an unknown risk factor. Disease stage at diagnosis was
assigned using BED testing, which is capable of providing a reasonable picture of HIV popula-
tion-level incidence in the United States [36, 37]. HIV-1 subtyping was performed using
SCUEAL [38]. For the purpose of this analysis, HIV-1 sequences were classified into B or non-
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B subtypes. Multivariate and univariate logistic regression analysis was used to model the
probability of an index case being genetically linked to at least one named partner.
Network analysis
To construct the genetic transmission network, we used HIV-TRACE (www.hivtrace.org), fol-
lowing a procedure described previously [23]. First, all HIV sequences were aligned to the
HXB2 (GenBank accession K03455) reference sequence (coordinates: 2253–3869) using an
extension of the Smith-Waterman algorithm [39], which aligns nucleotide sequences by con-
sidering amino-acid translations of constituent codons and corrects for possible frameshifts
and sequencing errors; as insertions and deletions are rare in this region and phylogenetically
uninformative, we filtered them from downstream analyses. The evolutionary conservation of
length in this genomic region permits pairwise alignment as a timesaving measure.
Next, we calculated the pairwise Tamura-Nei 93 (TN93; [40]) genetic distances among all
sequences. TN93 genetic distance was used because it can be computed rapidly via a closed-
form solution (i.e., not involving a numerical optimization) that requires only counts of
aligned nucleotide pairs as inputs and is the most complex evolutionary model (i.e., two types
of transitions rates, a transversion rate, and unequal base frequencies) that admits such a
closed form solution. Furthermore, for distances0.05 substitutions/site, all commonly used
nucleotide substitution models produce nearly identical estimates [41]. We then placed an
edge (link) connecting pairs of sequences that fell below a distance threshold. Connected com-
ponents of the resultant transmission network were interpreted as individual transmission
clusters. The potential confounding effect of convergent evolution for drug resistance was
assessed by repeating the analysis after excluding 48 codon positions in protease and reverse
transcriptase associated with drug resistance [42].
When calculating genetic distance between sequences, we resolved all IUPAC defined
nucleotide ambiguities (i.e., non-ACGT) to the corresponding nucleotide in the other
sequences (i.e., Y is zero distance from both C and T). Following the protocols established by
the Los Alamos National Laboratory HIV Sequence Database [http://www.hiv.lanl.gov/] to
curate problematic sequences, we excluded from the study 13 persons whose viral sequences
contained5% ambiguities.
To investigate the distribution of genetic distances among named partners, a mixture distri-
bution was defined as the weighted sum of a Gamma distribution (mean μ parameter and stan-
dard deviation σ), and a Gaussian (normal) distribution (with mean μ and standard deviation
σ), and the parameter p controlling the mixture weight (S1 Table). The Metropolis-Hastings
algorithm was used to estimate the parameters of this distribution. To improve mixing, the
Gamma parameters were transformed into means and standard deviations, and a uniform
(improper) prior was used over all parameters in this transformed parameter space. 200,000
MCMC samples were drawn, and the first 10,000 were discarded as burn-in. Mixing was
assessed visually.
Ethics statement
This study was a routine analysis of surveillance, laboratory, and partner services data reported
to the Department of Health as mandated by New York State Public Health Law. All patient
and partner matching was performed by authorized surveillance personnel. Cases and partners
were assigned identification numbers that were unique to this analysis and could only be
linked back to the original data by the same authorized personnel, in essence de-identifying
the analytic dataset. Consent was not required because these data were collected and analyzed
in the course of routine public health surveillance. The Institutional Review Board (IRB) of the
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University of California, San Diego Human Research Protections Program reviewed this study
and certified it exempt from IRB review, stating that this research involved “the study of exist-
ing data. . .and the information was provided in such a way that the subjects cannot not be
identified, directly or through identifiers linked to the subjects.”
Results
Study population and Field Services Unit (FSU) partner tracing
Between 2006 and 2012, the FSU identified 756 index cases who named 586 unique HIV-posi-
tive partners who also had an HIV-1 pol sequence reported to the DOHMH. This study
population was comprised mostly of individuals reporting MSM risk factor (44%), then het-
erosexual risk (32%) and injection drug use (8%). MSM index cases named more partners on
average (Table 1) and were slightly more likely than heterosexual females to have named part-
ners for whom an HIV genotype was available (incidence rate ratio = 1.18; 95% confidence
interval: 1.00–1.39; Poisson regression; p = 0.05). The mean number of named partners who
were genotyped did not vary significantly by race/ethnicity.
Genetic distance threshold
The distribution of genetic distances between viral sequences from index cases to all of their
named partners was bimodal (Fig 1), with the left component representing potential transmis-
sion partners and the right component representing sequences no more similar to each other
than two random isolates of the same subtype (i.e., 0.03 and 0.08 substitutions/site). We fit a
mixture distribution, the weighted sum of Gamma and Gaussian (normal) distributions, to
objectively assign distances to categories. We found that 99.9% of the probability mass of the
fitted normal component (mean = 0.058 substitutions/site; standard deviation = 0.012 substi-
tutions/site), representing unrelated pairings, was >0.02 substitutions/site. The Gamma distri-
bution, representing potential transmission partners, had a mean 0.008 substitutions/site and a
standard deviation of 0.006 substitutions/site (see S1 Table for more detail).
We performed our initial analyses using a genetic distance threshold of 0.0175 substitu-
tions/site, because this distance identifies the maximum number of clusters in the genetic net-
work (Fig 2). Above 0.0175 substitutions/site, clusters begin to coalesce and the network loses
Table 1. Mean number of named and genotyped partners by index case demographic characteristics.
Demographic Category1 Index cases Mean number of named partners (range) Mean number of genotyped partners (range)
Total - 756 2.3 (1–62) 1.1 (1–12)
Risk Hetero (F) 215 1.6 (1–8) 1.0 (1–2)
Hetero (M) 92 1.5 (1–6) 1.1 (1–2)
MSM 339 2.9 (1–50) 1.2 (1–5)
IDU (F) 15 1.6 (1–4) 1.0 (1–1)
IDU (M) 35 2.0 (1–9) 1.0 (1–2)
Other/Unknown 60 2.6 (1–62) 1.3 (1–12)
Race Black 390 2.1 (1–21) 1.1 (1–4)
Hispanic 306 2.3 (1–62) 1.1 (1–12)
White/Other 60 3.3 (1–50) 1.1 (1–2)
Hetero, heterosexual; MSM, men who have sex with men; IDU, injecting drug user
1Demographic categories reflect index case
doi:10.1371/journal.ppat.1006000.t001
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resolution. Nonetheless, we also explored the effect of using more conservative and liberal dis-
tance thresholds ranging between 0.01 and 0.02 substitutions/site.
Drug resistance associated mutations
Determination of genetic linkage was robust to the inclusion or exclusion of sites associated
with drug resistance (Fig 3), a possible confounding factor due to convergent evolution for
mutations conferring drug resistance. The agreement in classification (i.e., linked or not
linked) of partner pairs whose genetic distance was below the lower threshold for random
within subtype B variation (i.e., 0.03 substitutions/site) was 98% when their genetic distance
was calculated with or without codons associated with drug resistance using the 0.0175 dis-
tance threshold. If we were to exclude codons associated with drug resistance in the distance
calculation, two partner pairs would become unlinked and an additional six pairs would
become linked. All eight of these potential transmission partners that changed linkage due to
inclusion or exclusion of codons associated with drug resistance had distances near the cutoff
threshold. This pattern of general agreement in inference of partner pairs with or without the
inclusion of codons associated with drug resistance held across a range of distance thresholds
between 0.01 and 0.02 substitutions/site (Table 2).
Fig 1. Genetic distance (Tamura-Nei 93; TN93) separating index cases and named partners. Gray lines show the best-fitting mixture
distribution. Additional tick marks indicating epidemiologically plausible thresholds between 0.01 and 0.02 substitutions/site are shown on x-
axis. Blue denotes potential transmission partners (0.02 substitutions/site). Red denotes partners with “random” within or between subtype
viral divergence.
doi:10.1371/journal.ppat.1006000.g001
Social and Genetic HIV Networks
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Comparison of named partner and genetic networks
We constructed two networks in which nodes represent index cases and partners: a named
partner network and a genetic linkage network (Fig 4). To investigate which named partner-
ships are compatible with direct transmission, we mapped the genetic data to the named part-
ner network (Fig 4A).
Of the 651 recorded partner namings (i.e., edges in the named partner network), the genetic
data provide corroborating evidence for transmission along 48% (310/651) of these edges; the
genetic data effectively rule out transmission along the remaining 52% (341/651) of edges.
Importantly, these genetic distances that rule out transmission were not just slightly above the
threshold, but overwhelmingly represented random within subtype-diversity (0.03–0.08 sub-
stitutions/site divergence; Fig 1). To investigate which genetic links were supported by partner
tracing, and therefore more likely to represent direct transmission events, we also mapped the
partner naming data to the genetic network (Fig 4B). In the genetic network, we found 736
edges: pairs of viral sequences that were0.0175 substitutions/site apart. Partner naming pro-
vided evidence for direct transmission along 53% (388/736) of edges in this genetic network. It
is important to recognize that lack of direct partner naming does not definitively rule out
direct transmission but could be attributed to incomplete partner naming or other sampling
deficiencies. We also mapped the social and genetic data onto a single network (S1 Fig) to pro-
vide another perspective on the overlap and complementarity between these networks.
As the genetic distance threshold became more stringent (e.g., 0.01 substitutions/site), there
were fewer genetic links (466 edges), and a greater proportion of them were supported by part-
ner naming: 65% (304/466) of links (Fig 5; Table 2). At this conservative threshold, only 37%
(240/651) of partner namings corresponded to a genetic link. Using a more liberal but still
Fig 2. Number of genetic links and transmission clusters, as a function of the TN93 distance threshold. The epidemiologically
plausible range of thresholds between 0.01 and 0.02 substitutions/site is highlighted in gray.
doi:10.1371/journal.ppat.1006000.g002
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epidemiologically plausible distance threshold of 0.02 substitutions/site, a more densely con-
nected network with 918 genetic links was produced (Fig 2). As a consequence, a smaller pro-
portion of these genetic links were supported by partner naming (43%; 396/918), and more
partner namings were supported by genetic evidence (50%; 324/651). At the genetic distance
threshold commonly used for investigating HIV transmission network dynamics in a surveil-
lance population (i.e., 0.015 substitutions/site) [16, 43, 44], the results were similar (Table 2;
Fig 3. TN93 genetic distances between named partners0.03 substitutions/site including and excluding
codons associated with drug resistance. Disagreement in classification (linked/unlinked) between distance
models is shown in red. The line x = y is shown in solid gray. Dashed lines denote 1.75% genetic distance threshold.
doi:10.1371/journal.ppat.1006000.g003
Table 2. Sensitivity to genetic distance thresholds ranging between 0.01 and 0.02 substitutions/site.
Outcome Genetic distance threshold (substitutions/site) using TN93
distance
0.01 0.0125 0.015 0.0175 0.02
Genetic linkage agreement when excluding codons associated with drug resistance 95% 96% 96% 98% 98%
Index cases genetically linked to1 named partner (%) 46% 53% 57% 59% 60%
Index cases genetically linked to reciprocally named partner (%) 65% 72% 76% 79% 79%
Genetic links supported by partner namings (%) 65% 62% 57% 53% 43%
Partner namings supported by genetic links (%) 37% 42% 46% 48% 49%
doi:10.1371/journal.ppat.1006000.t002
Social and Genetic HIV Networks
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see S2 Fig for a detailed comparison at 0.015 substitutions/site). Across the entire range of vali-
dated genetic distance thresholds for establishing potential transmission partners, the genetic
evidence indicates that partner naming did not identify potential transmission partners in
more than half the cases (Fig 5; Table 2).
As the genetic distance threshold increases, connections in the genetic network become less
informative. Additional edges, rather than forming new clusters, tend to fill in already existing
clusters and bridge distinct clusters, creating accreted dense clusters in which nearly all mem-
bers are directly linked to each other, an epidemiologically uninformative scenario. This
unwanted scenario occurred above the epidemiologically plausible range of 0.01 to 0.02 substi-
tutions/site, thus providing additional evidence that a threshold within this range is ideal for
identifying potential transmission partners and clusters. Importantly, even when the genetic
distance threshold was extremely permissive (e.g., 0.04) and the number of genetic links
increased dramatically (47,573 edges; Fig 2), the proportion of partner namings supported by
genetic links was only slightly more than half: 55% (358/651) (Fig 5). In other words, nearly
half of named partners are infected with a virus that is no more related to the index case than a
random isolate of the same subtype.
Correlates of genetic linkage to named partner
Of the 756 index cases, 449 (59%) were genetically linked to at least one named partner at
0.0175 substitutions/site. The frequency at which an index case was genetically linked to one
or more named partners varied by risk group (Table 3). Heterosexual female and male index
Fig 4. Concordance between named partner and genetic networks. (A) Genetic data mapped onto named partner network. Edges
indicate partner naming. (B) Partner naming data mapped onto genetic network. Edges indicate genetic linkage (0.0175 substitutions/site).
doi:10.1371/journal.ppat.1006000.g004
Social and Genetic HIV Networks
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cases, were the most likely to be genetically linked to at least one named partner (77% of index
cases). In contrast, MSM index cases were significantly less likely than heterosexual females to
be genetically linked to at least one named partner (42% of index cases; p< 0.001). Index cases
who reported injection drug use were also less likely to be genetically linked to named partners
(53% of females and 43% of males; p = 0.061 and p< 0.001, respectively). Although Black/Afri-
can American index cases were significantly less likely to be genetically linked to a named
partner than Hispanics or Whites/Other (p< 0.001 and p = 0.014), the magnitudes of the dif-
ferences by race/ethnicity were smaller than those among risk groups (Table 3). Further, the
difference between risk groups was not driven solely by race/ethnicity. When the logistic
regression was restricted to Black/African American index cases or excluded Black/African
American index cases the adjusted odds ratios were essentially unchanged: 0.254 (0.143–0.451)
versus 0.214 (0.115–0.398).
There was an increased rate of genetic linkage to a named partner when the index case had
been diagnosed during the acute or early stages of infection (p = 0.040). It is unclear whether
this difference was due to increased infectiousness or transmission risk during acute/early
infection [45], better ability to recall recent high-risk behavior and partners, or limited
sequence evolution since transmission [46]. No significant association was found between
genetic linkage to a named partner and country of birth, HIV-1 subtype, AIDS status as of
2013, and age at diagnosis.
Fig 5. Proportion of partner namings and genetic links that agree, in relation to the TN93 genetic distance threshold. The
epidemiologically plausible range of thresholds between 0.01 and 0.02 substitutions/site is highlighted in gray.
doi:10.1371/journal.ppat.1006000.g005
Social and Genetic HIV Networks
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The associations between genetic linkage to at least one named partner were generally con-
sistent between the multivariate regression analysis (described above) and the univariate mod-
els (S2 Table). Foreign-born individuals were slightly more likely to be genetically linked to at
least named partner in the univariate analysis, but this association is not found in the multivar-
iate analysis. No differences in the importance of risk factor, race/ethnicity, stage of diagnoses,
subtype, or AIDS status were found between the models. These results were also qualitatively
similar when we compared the percentages of genetically linked named partners for each
index case (S3 Table), which accounts for different mean numbers of named partners among
demographic groups.
Genetic distance by risk factor
As illustrated earlier (Fig 1), the genetic distance between viruses from index cases and named
partners can be distinguished by two prominent modes: potential transmission partners and
random within subtype variants. This bimodal distribution was less evident when this analysis
was restricted to heterosexual couples with no evidence of IDU (Fig 6A). This difference may
Table 3. Logistic regression analysis of index case being genetically-linked to at least one of their named partners.
Demographic Category1 Index
cases
Genetically linked to1
named partner, n (%)
Not genetically linked to a
named partner, n (%)
Odds
Ratio2
95% confidence
interval
p-value
Total - 756 449 (59%) 307 (41%) - - -
Risk Hetero (F) 215 166 (77%) 49 (23%) 1 - -
Hetero (M) 92 71 (77%) 21 (23%) 1.06 0.58–1.94 0.861
MSM 339 143 (42%) 196 (58%) 0.22 0.14–0.33 <0.001
IDU (F) 15 8 (53%) 7 (47%) 0.35 0.12–1.05 0.061
IDU (M) 35 15 (43%) 20 (23%) 0.20 0.09–0.44 <0.001
Other/
Unknown
60 46 (77%) 14 (23%) 1.16 0.57–2.34 0.685
Race Black 390 209 (54%) 181 (46%) 1 - -
Hispanic 306 204 (67%) 102 (33%) 1.95 1.35–2.83 <0.001
White/Other 60 36 (60%) 24 (40%) 2.19 1.17–4.08 0.014
Country of birth USA 489 276 (56%) 213 (44%) 1 - -
Foreign 211 138 (65%) 73 (35%) 1.18 0.80–1.74 0.399
US
dependency
54 34 (63%) 20 (37%) 0.78 0.39–1.55 0.477
Unknown 2 1 (50%) 1 (50%) 0.43 0.02–9.09 0.589
Subtype B 700 413 (59%) 287 (41%) 1 - -
Non-B 56 36 (64%) 20 (36%) 0.93 0.50–1.74 0.831
Stage at
diagnosis
Chronic 207 119 (57%) 88 (43%) 1 - -
Acute/early 126 90 (71%) 36 (29%) 1.74 1.02–2.97 0.040
Unknown 423 240 (57%) 183 (43%) 1.05 0.72–1.53 0.802
AIDS status in
2013
Non-AIDS 432 258 (60%) 174 (40%) 1 - -
AIDS 324 191 (59%) 133 (41%) 0.85 0.60–1.19 0.338
Age at diagnosis - - - - 1.00 0.99–1.02 0.418
Named partners - - - - 0.91 0.85–0.99 0.023
Genotyped
partners
- - - - 1.34 0.90–2.01 0.154
Hetero, heterosexual; MSM, men who have sex with men; IDU, injecting drug user
1Demographic categories reflect index case
2Model adjusted odds ratio
doi:10.1371/journal.ppat.1006000.t003
Social and Genetic HIV Networks
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be partly attributable to the relatively high proportion of heterosexual males and females
that named a partner with a closely related virus (77%; Table 3). In MSM and partners who
reported IDU, there is a clear grouping of index cases who named partners whose viruses were
no more genetically similar than random isolates of the same subtype (Fig 6B and 6C). Among
partner pairs where at least one member was diagnosed with acute or early HIV infection, we
also we saw a marked distinction between index cases who named potential transmission part-
ners and index cases who identified partners with distantly related isolates (Fig 6D). Like het-
erosexual index cases, an index case with acute/early HIV diagnosis was highly predictive of
naming at least one genetically linked partner (Table 3). However, unlike in heterosexual part-
ners, the genetic distance separating partners with at least one acute/early diagnosis had a clear
bimodal distribution. This observation suggests that ability to identify potential transmission
partners is not strongly dependent on acute/early diagnosis.
Sensitivity analysis
Across the range of epidemiologically plausible distance thresholds (i.e., 0.01 to 0.02 substitu-
tions/site), the proportion of index cases who were genetically linked to at least one named
partner remained fairly consistent (46–60%; Table 2). More importantly, the statistical
Fig 6. Genetic distance (TN93) separating index cases and named partners in select risk groups. (A) Genetic distance between
named heterosexual partners. (B) Genetic distance between named MSM partners. (C) Genetic distance between named partners where at
least one partner reported injection drug use (IDU). (D) Genetic distance between named partners where at least one partner was diagnosed
with acute or early HIV infection. Additional tick marks on the x-axis indicate epidemiologically plausible thresholds between 0.01 and 0.02
substitutions/site are shown on x-axis. Blue denotes potential transmission partners (0.02 substitutions/site). Red denotes partners with
“random” within or between subtype viral divergence.
doi:10.1371/journal.ppat.1006000.g006
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associations found between genetic linkage and risk factor, race/ethnicity, and stage of infec-
tion were qualitatively similar.
Index cases who named more partners were slightly less likely to be genetically linked to
any of these partners (p = 0.023; Table 3). There was no significant relationship between an
index case being genetically linked to at least one named partner and the number of named
partners who were genotyped. Because inclusion in our study required at least one named
partner to have a reported genotype, it could be possible that MSM index cases had a lower
probability of genetic linkage simply because a lower proportion of their named partners had a
reported genotype, compared to other risk groups. Therefore, we reanalyzed the data restrict-
ing the analysis to index cases who provided only one named partner. MSM index cases who
named only one partner were still less likely to be genetically linked to their single named part-
ner than heterosexual index cases (p< 0.001; S4 Table).
Reciprocally named partners
A total of 239 HIV-positive named partners were interviewed by the FSU to elicit additional
named partners; these persons were also considered index cases in their own right. For 189
index cases, their named partner independently named the original index case during the
interview. Such reciprocal naming increased the odds that named partners would be geneti-
cally linked compared to unidirectionally named partners: model adjusted odds ratio = 3.72
(95% confidence interval: 2.43–5.69). Nearly 4 out of 5 (149/189) reciprocally named partner
pairs were also genetically linked (Table 4). The rate of genetic linkage increased for all risk
groups relative to unidirectional naming: 90% of the time for female heterosexual index cases
and 64% of the time for MSM index cases. This pattern was observed across a range of genetic
distance thresholds (Table 2).
Discussion
We analyzed an unprecedentedly expansive and detailed partner tracing and HIV sequence
dataset collected from 1342 HIV-infected persons in New York City between 2006 and 2012
and determined an empirically justified and epidemiological plausible range of genetic dis-
tance thresholds for identifying potential transmission partners. Over this range of genetic dis-
tance thresholds, if an index case named an identifiable partner who tested positive for HIV, a
genetic link indicating transmission was absent more than 50% of the time. Therefore,
Table 4. Index cases who were reciprocally named by their named partner (n = 189 partner pairs).
Demographic Category1 Index cases Genetically linked, n (%) Not genetically linked, n (%)
Total - 189 149 (79%) 40 (21%)
Risk Hetero (F) 51 46 (90%) 5 (10%)
Hetero (M) 28 24 (86%) 4 (14%)
MSM 78 50 (64%) 28 (36%)
IDU (F) 6 5 (83%) 1 (17%)
IDU (M) 4 3 (75%) 1 (25%)
Other/Unknown 22 21 (95%) 1 (5%)
Race3 Black 84 57 (68%) 27 (32%)
Hispanic 92 81 (88%) 11 (12%)
White/Other 13 11 (85%) 2 (15%)
Hetero, heterosexual; MSM, men who have sex with men; IDU, injecting drug user
1Demographic categories are tabulated based on index cases
doi:10.1371/journal.ppat.1006000.t004
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according to the genetic data, at least half of named partners are not plausible transmission
partners; their HIV-1 sequences are no more similar to the HIV-1 sequence isolated from the
corresponding index case sequences than to a randomly chosen sequence of the same HIV-1
subtype. Encouragingly, if both partners named each other, the odds of genetic linkage
increased significantly across all transmission risk factors.
We found that despite naming more partners per index case than heterosexuals, MSM were
less likely to name any partners with genetically linked viruses. Black/African American index
cases, compared with Hispanic and White/Other index cases, were less likely to name a partner
with genetically linked viruses. When an index case was reciprocally named by their named
partner, the odds of infection with a genetically linked virus increased for all risk and race/eth-
nicity groups. This observation highlights the importance of reciprocal naming in identifying
potential transmission partners.
Although one should never expect perfect concordance between social and genetic net-
works, their relative overlap provides insight into their respective usefulness in guiding public
health interventions. Genetic transmission links were supported between 43% and 65% of the
time by partner tracing information, depending on the genetic distance threshold. Impor-
tantly, lack of naming does not contradict the genetic inference. Rather, it can be attributable
to an absence of evidence, not evidence of absence. If two genetically linked individuals are not
named partners, it may be due to incomplete partner enumeration, thus highlighting the diffi-
culty in eliciting the names of transmission partners. The proportion of genetic links sup-
ported by partner naming data can be viewed as the lower bound on the proportion of genetic
links that represent recent transmission events in the network. Therefore, over a range of epi-
demiologically plausible genetic distance thresholds, genetic data are at least as good, and
almost certainly better, than partner tracing data for inferring HIV recent transmission part-
ners, despite known issues in genetic sequence analysis (e.g., spurious transitive edges in
densely connected clusters). Furthermore, genetic data can help filter out reported at-risk con-
tacts that did not lead to transmission, providing independent evidence for absence of a trans-
mission event between named partners.
We recommend using a genetic distance threshold between 0.01 and 0.02 substitutions/site
for identifying potential transmission partners in a surveillance setting. Admittedly, the
approach to validating this cutoff will be biased towards detecting more recent transmission
partners; however, this bias can be advantageous from a public health perspective, where the
goal may be to identify recent partners in a growing transmission cluster. It is nontrivial to
define a specific threshold systematically, because threshold tuning is always an exercise in bal-
ancing sensitivity and specificity. For example, when using genetic distance comparisons in
typical HIV surveillance datasets that are not restricted to named partners, we suggest using a
more conservative genetic threshold (e.g., 0.01 to 0.015) to identify partners with an epidemio-
logically meaningful relationship. Nevertheless, our findings confirm previous work showing
that genetic distance information can be used to identify potential transmission partners in
both early [17, 26] and chronic [11, 15] infection. These findings also suggest that using a
genetic distance threshold without relying on phylogenetic tree inference and interpretation
(as in [16, 21, 23, 43, 44]) is a valid approach for identifying potential transmission partners.
Because financial and personnel resources needed for exhaustive partner tracing are not
feasible, genetic transmission networks inferred from sequences collected during routine drug
resistance screening represent a relatively easy and inexpensive method for reconstructing the
transmission history of HIV. Nevertheless, our study shows that there is great value in collect-
ing partner-tracing data. For example, many named partners who, according to genetic data
collected after diagnosis, are unlikely to be direct transmission partners, are HIV-positive but
undiagnosed/unaware until they are offered HIV testing through the partner services program
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offered by the FSU. Therefore, partner tracing discovers HIV-infected persons who may not
have been previously known to public health officials, allowing these persons to enter care and
expanding the scope of potential intervention across the transmission network. Identifying
these persons, regardless of whether they were previously known to surveillance, allows field
workers to contact them, ensure linkage or return to care, elicit and notify partners, and
expand the network of persons in the city that are receiving public health services. For exam-
ple, 15.3% (81/448) of named partners in the genetic network linked only to someone other
than the index case who named them; therefore, it is possible that simply being a named part-
ner indicates an elevated risk status and possibly increased importance in the network (i.e., an
intervention-worthy case) [26, 33].
To maximize the probability of finding transmission partners, the geographic scope of sur-
veillance and comparison should be as broad as possible. In other studies of HIV transmission
in citywide epidemics in Uganda, United Kingdom, and the United States [17, 47–49], only
30% of new infections can be identified as having originated in a given city. Even though the
FSU interviews partners in the greater metropolitan region surrounding New York City, it is
likely that many transmission partners reside outside their reach. Expanded collaboration and
coordination among public health departments could help identify these geographically dis-
persed transmission events.
In addition, index cases who are not genetically linked to any of their named partners may
be attractive candidates for additional interviews to identify potential transmission partners
and expand network surveillance. On the other hand, because persons who named more part-
ners were less likely to be genetically linked to any of their named partners, additional follow-
up interviews may fail to meaningfully expand the scope of the network. To determine the
value of repeated interviews, it will be important to record whether their “second round” of
named partners were HIV-positive, linked to care, and yielded a viral genotype.
Identifying transmission partners is of critical importance in combating HIV, because HIV
transmission networks tend to be best described by preferential attachment (or more generally,
scale-free) models [15, 23], in which certain groups of highly connected individuals are central
to the propagation of the epidemic. This scale-free property is inherited from the underlying
social and contact networks [50]. Importantly, scale-free networks cannot be reliably disrupted
by incomplete random interventions: only network-guided interventions targeted at transmis-
sion hubs (i.e., core transmitters and associated venues) can successfully combat the epidemic
[15, 17, 50]. By identifying clusters that grew disproportionately in the past, we may be able to
predict which clusters hold the greatest potential for future growth. Unfortunately, the time
delay between HIV diagnosis/interview and genotype acquisition by the DOHMH (i.e., 6
months in our study, though this delay has shrunk since 2012) represents an impediment to
prompt network-based intervention. Point-of-diagnosis-genotyping coupled with real-time
genetic network analysis to identify potential transmission partners could help interdict ongo-
ing transmission and target prevention, linkage to care, and treatment more effectively (as
recent suggested in [18]).
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